Molnupiravir, the oral pill for COVID-19, may actually be driving the emergence of new, potentially harmful, variants of the virus, according to a Wellcome Trust-funded study at the pre-print stage.
Legislation that would eliminate a requirement that most foreign travelers arriving in the U.S. be vaccinated against COVID-19 passed the House Wednesday.
On Dec. 13, 2022, the World Health Organisation (WHO) announced that Sir Jeremy Farrar, the current director of the Wellcome Trust, would be joining it as its chief scientist.
